Intravenous golimumab is both safe and effective over a one-year treatment period for patients with psoriatic arthritis. Rheumatologist Elaine Husnie, MD, MPH, discusses the findings.
Read MoreSearch Is On for Genomic Clues in Psoriatic Arthritis
Here’s why psoriatic arthritis is among the first clinical areas Cleveland Clinic’s collaborative Center for Clinical Genomics has chosen to focus on.
New Research Lab Brings an Interdisciplinary Approach to Psoriatic Diseases
The Husni research lab combines clinical savvy with biochemical and molecular biology expertise to home in on the molecular basis of immune-mediated diseases. An early focus: selective TNF-α receptor inhibition.
Zoster and Patients on Biologics: To Vaccinate or Not?
A new multicenter study aims to clarify whether and when to consider zoster vaccination in patients taking anti-TNF therapies or other immune-modulating biologics.
Case Study: Here’s Why Renal Biopsy Is Imperative in Lupus Nephritis
This case of a young woman found to have lupus nephritis and antiphospholipid syndrome shows how renal biopsy can establish the pattern of injury and guide immunosuppressive therapy.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
How Biologics Are Shaping Cancer and MS
Cancer and multiple sclerosis were among the focus areas in a unique session at the Biologic Therapies VI Summit in which experts from six diverse disciplines shared how biologics are being used in their specialties.
Biological Cross Fire: Takeaways from the Biologic Therapies Summit
A session at the recent Biologic Therapies VI Summit brought together six experts from diverse disciplines to share how biologics are being used in their specialties. We spotlight the rheumatology and psoriasis portions.
Improvement Seen in Use of Abatacept in Nonsevere Relapsing Granulomatosis with Polyangiitis (Wegener’s)
In a small study of patients with nonsevere relapsing GPA, abatacept was well tolerated and was associated with a high frequency of disease remission and prednisone discontinuation.
How Can Biobanking Advance Rheumatology Practice?
Biobanking is an increasingly integral part of Cleveland Clinic’s Department of Rheumatic and Immunologic Diseases, providing insights that improve patient outcomes in many areas.